Trials / Not Yet Recruiting
Not Yet RecruitingNCT05616182
Application of LARS Ligament in Bone Prosthesis Replacement
A Prospective, Real-world, Single-center, Cohort Study of LARS Ligaments in Bone Tumors
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Henan Cancer Hospital · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a single-center, prospective, real-world observational study designed to enroll all patients eligible for enrollment. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.
Detailed description
This is a single-center prospective real-world observational study of 100 eligible patients with bone tumors who are scheduled to undergo LARS ligament implantation and/or bone prosthesis replacement in Henan Cancer Hospital in the next 10 years. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | LARS ligament and bone prosthesis replacement was performed | To report the postoperative complications and limb function of patients who underwent LARS ligament and bone prosthesis replacement in Henan Cancer Hospital. |
Timeline
- Start date
- 2024-12-30
- Primary completion
- 2032-02-28
- Completion
- 2032-02-28
- First posted
- 2022-11-15
- Last updated
- 2024-01-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05616182. Inclusion in this directory is not an endorsement.